AYTU vs DGX · rev $66.4M vs P/E 22, rev $5.94B
Aytu BioScience Inc (AYTU) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
AYTU currently screens at market cap $24.1M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the AYTU and DGX stock pages for the full models.
Not investment advice.